Total Payments
$25,789
2024 Payments
$334.98
Companies
13
Transactions
73
Medicare Patients
223
Medicare Billing
$22,253
Payment Breakdown by Category
Other$18,600 (72.1%)
Travel$4,150 (16.1%)
Food & Beverage$2,727 (10.6%)
Education$310.99 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $18,600 | 14 | 72.1% |
| Travel and Lodging | $4,150 | 10 | 16.1% |
| Food and Beverage | $2,727 | 44 | 10.6% |
| Education | $310.99 | 5 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $22,492 | 39 | $0 (2021) |
| NeoTract Inc. | $839.63 | 5 | $0 (2019) |
| ABBVIE INC. | $817.79 | 2 | $0 (2022) |
| Verity Pharmaceuticals Inc. | $415.51 | 4 | $0 (2024) |
| Boston Scientific Corporation | $337.55 | 6 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $186.46 | 6 | $0 (2024) |
| PFIZER INC. | $164.99 | 3 | $0 (2024) |
| Janssen Biotech, Inc. | $146.00 | 2 | $0 (2021) |
| Olympus Latin America, Inc. | $130.00 | 1 | $0 (2024) |
| Retrophin, Inc. | $117.64 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $334.98 | 4 | Olympus Latin America, Inc. ($130.00) |
| 2023 | $220.78 | 4 | Verity Pharmaceuticals Inc. ($165.61) |
| 2022 | $889.00 | 2 | ABBVIE INC. ($800.00) |
| 2021 | $2,048 | 5 | Allergan, Inc. ($1,800) |
| 2020 | $3,596 | 7 | Allergan, Inc. ($3,596) |
| 2019 | $9,216 | 30 | Allergan Inc. ($7,843) |
| 2018 | $9,466 | 20 | Allergan Inc. ($9,253) |
| 2017 | $17.79 | 1 | AbbVie, Inc. ($17.79) |
All Payment Transactions
73 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Janssen Pharmaceuticals, Inc | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Olympus Latin America, Inc. | SOLTIVE (Device) | Food and Beverage | In-kind items and services | $130.00 | General |
| Category: Urology Gynecology | ||||||
| 10/15/2024 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $54.99 | General |
| Category: ONCOLOGY | ||||||
| 08/29/2024 | Verity Pharmaceuticals Inc. | Tlando (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Testosterone Replacement Therapy (TRT) | ||||||
| 04/24/2023 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $20.03 | General |
| Category: Prostate cancer | ||||||
| 04/21/2023 | TOLMAR, INC. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $22.07 | General |
| Category: Endogenous Testosterone Replacement Therapy | ||||||
| 03/23/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $33.10 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/23/2023 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | Cash or cash equivalent | $145.58 | General |
| Category: Prostate cancer | ||||||
| 06/28/2022 | PFIZER INC. | XTANDI (Drug) | Education | In-kind items and services | $89.00 | General |
| Category: ONCOLOGY | ||||||
| 06/27/2022 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| Category: UROLOGY | ||||||
| 09/28/2021 | PFIZER INC. | ORGOVYX (Drug) | Education | In-kind items and services | $21.00 | General |
| Category: ONCOLOGY | ||||||
| 06/29/2021 | Verity Pharmaceuticals Inc. | Trelstar (Drug) | Food and Beverage | In-kind items and services | $124.91 | General |
| Category: Prostate cancer | ||||||
| 05/26/2021 | Allergan, Inc. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| Category: UROLOGY | ||||||
| 04/21/2021 | Janssen Pharmaceuticals, Inc | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Oncology | ||||||
| 01/14/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Education | In-kind items and services | $85.00 | General |
| Category: Oncology | ||||||
| 09/25/2020 | Allergan, Inc. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $600.00 | General |
| Category: UROLOGY | ||||||
| 06/04/2020 | Allergan, Inc. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: UROLOGY | ||||||
| 06/01/2020 | Allergan, Inc. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: UROLOGY | ||||||
| 06/01/2020 | Allergan, Inc. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: UROLOGY | ||||||
| 05/28/2020 | Allergan, Inc. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: UROLOGY | ||||||
| 02/19/2020 | Allergan, Inc. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: UROLOGY | ||||||
| 02/19/2020 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $96.30 | General |
| Category: UROLOGY | ||||||
| 11/18/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Education | In-kind items and services | $61.00 | General |
| Category: Oncology | ||||||
| 10/30/2019 | Allergan Inc. | BOTOX (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,500.00 | General |
| Category: UROLOGY | ||||||
| 10/30/2019 | Allergan Inc. | BOTOX (Drug) | Food and Beverage | In-kind items and services | $100.00 | General |
| Category: UROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 46 | 54 | $8,325 | $3,748 |
| 2022 | 2 | 58 | 76 | $13,175 | $5,678 |
| 2021 | 2 | 59 | 74 | $12,532 | $6,815 |
| 2020 | 1 | 60 | 85 | $9,419 | $6,012 |
Total Patients
223
Total Services
289
Medicare Billing
$22,253
Procedure Codes
7
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 27 | 33 | $4,125 | $2,143 | 52.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 19 | 21 | $4,200 | $1,604 | 38.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 37 | 49 | $9,800 | $4,242 | 43.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 27 | $3,375 | $1,436 | 42.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 46 | 61 | $10,285 | $5,544 | 53.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 13 | 13 | $2,247 | $1,271 | 56.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 60 | 85 | $9,419 | $6,012 | 63.8% |
About Dr. Alberto Ramirez, MD
Dr. Alberto Ramirez, MD is a Urology healthcare provider based in Dorado, Puerto Rico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1437134897.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alberto Ramirez, MD has received a total of $25,789 in payments from pharmaceutical and medical device companies, with $334.98 received in 2024. These payments were reported across 73 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($18,600).
As a Medicare-enrolled provider, Ramirez has provided services to 223 Medicare beneficiaries, totaling 289 services with total Medicare billing of $22,253. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Dorado, PR
- Active Since 12/08/2005
- Last Updated 10/30/2023
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1437134897
Products in Payments
- BOTOX (Biological) $15,438
- BOTOX (Drug) $7,843
- UroLift (Device) $839.63
- Trelstar (Drug) $290.52
- XTANDI (Drug) $143.99
- SOLTIVE (Device) $130.00
- ERLEADA (Drug) $126.79
- Tlando (Drug) $124.99
- GENERAL KIDNEY STONE DISEASE (Device) $117.74
- (815) Thiola (Drug) $117.64
- XARELTO (Drug) $109.19
- REZUM (Device) $102.81
- KEYTRUDA (Biological) $100.00
- Erleada (Drug) $96.48
- GENERAL BPH (Device) $95.79
- JATENZO (Drug) $22.07
- GENERAL BPH (Device) $21.21
- ORGOVYX (Drug) $21.00
- NOCDURNA (Drug) $18.82
- Lupron (Drug) $17.79
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.